BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy
Titel:
BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy
Auteur:
Wiesweg, Marcel Preuß, Cedric Roeper, Julia Metzenmacher, Martin Eberhardt, Wilfried Stropiep, Ursula Wedeken, Katrin Reis, Henning Herold, Thomas Darwiche, Kaid Aigner, Clemens Stuschke, Martin Schildhaus, Hans-Ulrich Schmid, Kurt W. Falk, Markus Heukamp, Lukas Tiemann, Markus Griesinger, Frank Schuler, Martin